SOCS1 and hepatocellular carcinoma: This notion indicates that miR‐29a repression by specific miR‐29a inhibitors in highly metastatic cells decreases the metastatic potential as well as increase the expression of TET proteins and SOCS1; this phenomenon represents a novel scheme for a therapeutic intervention that inhibits HCC metastatic phenotypes.